<!DOCTYPE html><html lang="en-us" >

<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  
  
  
    <meta name="generator" content="Wowchemy 5.2.0 for Hugo" />
  

  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Qi Zhao" />

  
  
  
    
  
  <meta name="description" content="Objective To monitor trastuzumab resistance and determine the underlying mechanisms for the limited response rate and rapid emergence of resistance of HER2&#43; metastatic gastric cancer (mGC).
Design Targeted sequencing of 416 clinically relevant genes was performed in 78 paired plasma and tissue biopsy samples to determine plasma-tissue concordance. Then, we performed longitudinal analyses of 97 serial plasma samples collected from 24 patients who were HER2&#43;  to track the resistance during trastuzumab treatment and validated the identified candidate resistance genes.
Results The results from targeted sequencing-based detection of somatic copy number alterations (SCNA) of HER2 gene were highly consistent with fluorescence in situ hybridisation data, and the detected HER2 SCNA was better than plasma carcinoembryonic antigen levels at predicting tumour shrinkage and progression. Furthermore, most patients with innate trastuzumab resistance presented high HER2 SCNA during progression compared with baseline, while HER2 SCNA decreased in patients with acquired resistance. PIK3CA mutations were significantly enriched in patients with innate resistance, and ERBB2/4 genes were the most mutated genes, accounting for trastuzumab resistance in six (35.3%) and five (29.4%) patients in baseline and progression plasma, respectively. Patients with PIK3CA/R1/C3 or ERBB2/4 mutations in the baseline plasma had significantly worse progression-free survival. Additionally, mutations in NF1 contributed to trastuzumab resistance, which was further confirmed through in vitro and in vivo studies, while combined HER2 and MEK/ERK blockade overcame trastuzumab resistance.
Conclusion Longitudinal circulating tumour DNA sequencing provides novel insights into gene alterations underlying trastuzumab resistance in HER2&#43;mGC." />

  
  <link rel="alternate" hreflang="en-us" href="https://likelet.github.io/publication/journal-article-liquid/" />

  







  




  
  
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
  

  
  
  
    <meta name="theme-color" content="#1565c0" />
  

  
  

  
  
  
  
    
    
      <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.9.0/css/academicons.min.css" integrity="sha512-W4yqoT1+8NLkinBLBZko+dFB2ZbHsYLDdr50VElllRcNt2Q4/GSs6u71UHKxB7S6JEMCp5Ve4xjh3eGQl/HRvg==" crossorigin="anonymous">
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.14.0/css/all.min.css" integrity="sha256-FMvZuGapsJLjouA6k7Eo2lusoAX9i0ShlWFG6qt7SLc=" crossorigin="anonymous">

    
    

    
    
    
      
    
    

    
    
    
      <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.7.1/leaflet.min.css" integrity="sha512-1xoFisiGdy9nvho8EgXuXvnpR5GAMSjFwp40gSRE3NwdUdIMIKuPa7bqoUhLD0O/5tPNhteAsE5XyyMi5reQVA==" crossorigin="anonymous" media="print" onload="this.media='all'">
    

    

    
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      
        
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
  

  
  
  
    
      
      
      <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lato:400,700%7CMerriweather%7CRoboto+Mono&display=swap">
      
    
  

  
  
  
  
  
  <link rel="stylesheet" href="/css/wowchemy.84f6d3f2750c6dae1259b2f1b92da214.css" />

  



  

  

  




  
  
  

  

  
    <link rel="manifest" href="/index.webmanifest" />
  

  <link rel="icon" type="image/png" href="/media/icon_huc92b86c516357a0134b7c1ec7b6a518b_64366_32x32_fill_lanczos_center_3.png" />
  <link rel="apple-touch-icon" type="image/png" href="/media/icon_huc92b86c516357a0134b7c1ec7b6a518b_64366_180x180_fill_lanczos_center_3.png" />

  <link rel="canonical" href="https://likelet.github.io/publication/journal-article-liquid/" />

  
  
  
  
  
  
  
  
    
    
  
  
  <meta property="twitter:card" content="summary" />
  
  <meta property="og:site_name" content="Qizhao Lab" />
  <meta property="og:url" content="https://likelet.github.io/publication/journal-article-liquid/" />
  <meta property="og:title" content="Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer | Qizhao Lab" />
  <meta property="og:description" content="Objective To monitor trastuzumab resistance and determine the underlying mechanisms for the limited response rate and rapid emergence of resistance of HER2&#43; metastatic gastric cancer (mGC).
Design Targeted sequencing of 416 clinically relevant genes was performed in 78 paired plasma and tissue biopsy samples to determine plasma-tissue concordance. Then, we performed longitudinal analyses of 97 serial plasma samples collected from 24 patients who were HER2&#43;  to track the resistance during trastuzumab treatment and validated the identified candidate resistance genes.
Results The results from targeted sequencing-based detection of somatic copy number alterations (SCNA) of HER2 gene were highly consistent with fluorescence in situ hybridisation data, and the detected HER2 SCNA was better than plasma carcinoembryonic antigen levels at predicting tumour shrinkage and progression. Furthermore, most patients with innate trastuzumab resistance presented high HER2 SCNA during progression compared with baseline, while HER2 SCNA decreased in patients with acquired resistance. PIK3CA mutations were significantly enriched in patients with innate resistance, and ERBB2/4 genes were the most mutated genes, accounting for trastuzumab resistance in six (35.3%) and five (29.4%) patients in baseline and progression plasma, respectively. Patients with PIK3CA/R1/C3 or ERBB2/4 mutations in the baseline plasma had significantly worse progression-free survival. Additionally, mutations in NF1 contributed to trastuzumab resistance, which was further confirmed through in vitro and in vivo studies, while combined HER2 and MEK/ERK blockade overcame trastuzumab resistance.
Conclusion Longitudinal circulating tumour DNA sequencing provides novel insights into gene alterations underlying trastuzumab resistance in HER2&#43;mGC." /><meta property="og:image" content="https://likelet.github.io/media/icon_huc92b86c516357a0134b7c1ec7b6a518b_64366_512x512_fill_lanczos_center_3.png" />
    <meta property="twitter:image" content="https://likelet.github.io/media/icon_huc92b86c516357a0134b7c1ec7b6a518b_64366_512x512_fill_lanczos_center_3.png" /><meta property="og:locale" content="en-us" />
  
    
      <meta
        property="article:published_time"
        content="2019-01-01T00:00:00&#43;00:00"
      />
    
    <meta property="article:modified_time" content="2019-01-01T00:00:00&#43;00:00">
  

  


    









<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://likelet.github.io/publication/journal-article-liquid/"
  },
  "headline": "Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer",
  
  "datePublished": "2019-01-01T00:00:00Z",
  "dateModified": "2019-01-01T00:00:00Z",
  
  "author": {
    "@type": "Person",
    "name": "De-Shen Wang"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "Qizhao Lab",
    "logo": {
      "@type": "ImageObject",
      "url": "https://likelet.github.io/media/icon_huc92b86c516357a0134b7c1ec7b6a518b_64366_192x192_fill_lanczos_center_3.png"
    }
  },
  "description": "Objective To monitor trastuzumab resistance and determine the underlying mechanisms for the limited response rate and rapid emergence of resistance of HER2+ metastatic gastric cancer (mGC).\nDesign Targeted sequencing of 416 clinically relevant genes was performed in 78 paired plasma and tissue biopsy samples to determine plasma-tissue concordance. Then, we performed longitudinal analyses of 97 serial plasma samples collected from 24 patients who were HER2+  to track the resistance during trastuzumab treatment and validated the identified candidate resistance genes.\nResults The results from targeted sequencing-based detection of somatic copy number alterations (SCNA) of HER2 gene were highly consistent with fluorescence in situ hybridisation data, and the detected HER2 SCNA was better than plasma carcinoembryonic antigen levels at predicting tumour shrinkage and progression. Furthermore, most patients with innate trastuzumab resistance presented high HER2 SCNA during progression compared with baseline, while HER2 SCNA decreased in patients with acquired resistance. PIK3CA mutations were significantly enriched in patients with innate resistance, and ERBB2/4 genes were the most mutated genes, accounting for trastuzumab resistance in six (35.3%) and five (29.4%) patients in baseline and progression plasma, respectively. Patients with PIK3CA/R1/C3 or ERBB2/4 mutations in the baseline plasma had significantly worse progression-free survival. Additionally, mutations in NF1 contributed to trastuzumab resistance, which was further confirmed through in vitro and in vivo studies, while combined HER2 and MEK/ERK blockade overcame trastuzumab resistance.\nConclusion Longitudinal circulating tumour DNA sequencing provides novel insights into gene alterations underlying trastuzumab resistance in HER2+mGC."
}
</script>

  

  

  

  





  <title>Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer | Qizhao Lab</title>
</head>


<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="page-wrapper   " data-wc-page-id="0e311c9967d2c2b5ea053f963a6d9529" >

  
  
  
  
  
  
  
  
  
  <script src="/js/wowchemy-init.min.c2ae95842e5b33a787c7b8c567e989a4.js"></script>

  


<aside class="search-modal" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#" aria-label="Close"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search" class="form-control"
        aria-label="Search...">
        
      </div>

      
      

      

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>



  <div class="page-header">
    












<nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
  <div class="container-xl">

    
    <div class="d-none d-lg-inline-flex">
      <a class="navbar-brand" href="/">Qizhao Lab</a>
    </div>
    

    
    <button type="button" class="navbar-toggler" data-toggle="collapse"
            data-target="#navbar-content" aria-controls="navbar-content" aria-expanded="false" aria-label="Toggle navigation">
    <span><i class="fas fa-bars"></i></span>
    </button>
    

    
    <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
      <a class="navbar-brand" href="/">Qizhao Lab</a>
    </div>
    

    
    
    <div class="navbar-collapse main-menu-item collapse justify-content-end" id="navbar-content">

      
      <ul class="navbar-nav d-md-inline-flex">
        

        

        
        
        

        

        
        
        
        

        
          
            
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/post"><span>News</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/people"><span>People</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/publication"><span>Publications</span></a>
        </li>

        
        

        

        
        
        
          
        

        

        
        
        
        

        
          
            
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/contact"><span>Contact</span></a>
        </li>

        
        

      

        
      </ul>
    </div>

    <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">

      
      
        
      

      
      
      <li class="nav-item">
        <a class="nav-link js-search" href="#" aria-label="Search"><i class="fas fa-search" aria-hidden="true"></i></a>
      </li>
      

      
      

      
      

    </ul>

  </div>
</nav>


  </div>

  <div class="page-body">
    








<div class="pub">

  












  

  
  
  
<div class="article-container pt-3">
  <h1>Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer</h1>

  

  
    


<div class="article-metadata">

  
  
  
  
  <div>
    

  <span >
      <a href="/author/de-shen-wang/">De-Shen Wang</a></span>, <span >
      <a href="/author/ze-xian-liu/">Ze-xian Liu</a></span>, <span >
      <a href="/author/yun-xin-lu/">Yun-xin Lu</a></span>, <span >
      <a href="/author/hua-bao/">Hua Bao</a></span>, <span >
      <a href="/author/xue-wu/">Xue Wu</a></span>, <span >
      <a href="/author/zhao-lei-zeng/">Zhao-lei Zeng</a></span>, <span >
      <a href="/author/zekun-liu/">Zekun Liu</a></span>, <span >
      <a href="/author/qi-zhao/">Qi Zhao</a></span>, <span >
      <a href="/author/cai-yun-he/">Cai-Yun He</a></span>, <span >
      <a href="/author/jia-huan-lu/">Jia-Huan Lu</a></span>, <span >
      <a href="/author/others/">others</a></span>
  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    January 2019
  </span>
  

  

  

  
  
  
  
  
  

  
  

</div>

    




<div class="btn-links mb-3">
  
  








  





<a href="#" class="btn btn-outline-primary btn-page-header js-cite-modal"
        data-filename="/publication/journal-article-liquid/cite.bib">
  Cite
</a>





  
    
  









<a class="btn btn-outline-primary btn-page-header" href="https://doi.org/http://dx.doi.org/10.1136/gutjnl-2018-316522" target="_blank" rel="noopener">
  DOI
</a>



</div>


  
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract">Objective To monitor trastuzumab resistance and determine the underlying mechanisms for the limited response rate and rapid emergence of resistance of HER2+ metastatic gastric cancer (mGC).
Design Targeted sequencing of 416 clinically relevant genes was performed in 78 paired plasma and tissue biopsy samples to determine plasma-tissue concordance. Then, we performed longitudinal analyses of 97 serial plasma samples collected from 24 patients who were HER2+  to track the resistance during trastuzumab treatment and validated the identified candidate resistance genes.
Results The results from targeted sequencing-based detection of somatic copy number alterations (SCNA) of HER2 gene were highly consistent with fluorescence in situ hybridisation data, and the detected HER2 SCNA was better than plasma carcinoembryonic antigen levels at predicting tumour shrinkage and progression. Furthermore, most patients with innate trastuzumab resistance presented high HER2 SCNA during progression compared with baseline, while HER2 SCNA decreased in patients with acquired resistance. PIK3CA mutations were significantly enriched in patients with innate resistance, and ERBB2/4 genes were the most mutated genes, accounting for trastuzumab resistance in six (35.3%) and five (29.4%) patients in baseline and progression plasma, respectively. Patients with PIK3CA/R1/C3 or ERBB2/4 mutations in the baseline plasma had significantly worse progression-free survival. Additionally, mutations in NF1 contributed to trastuzumab resistance, which was further confirmed through in vitro and in vivo studies, while combined HER2 and MEK/ERK blockade overcame trastuzumab resistance.
Conclusion Longitudinal circulating tumour DNA sequencing provides novel insights into gene alterations underlying trastuzumab resistance in HER2+mGC.</p>
    

    
    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            <a href="/publication/#2">
              Journal article
            </a>
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9">Gut</div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style"><div class="alert alert-note">
  <div>
    Click the <em>Cite</em> button above to demo the feature to enable visitors to import publication metadata into their reference management software.
  </div>
</div>
<p>Supplementary notes can be added here, including <a href="https://sourcethemes.com/academic/docs/writing-markdown-latex/" target="_blank" rel="noopener">code and math</a>.</p>
</div>

    




<div class="article-tags">
  
  <a class="badge badge-light" href="/tag/source-themes/">Source Themes</a>
  
</div>



<div class="share-box" aria-hidden="true">
  <ul class="share">
    
      
      
      
        
      
      
      
      <li>
        <a href="https://twitter.com/intent/tweet?url=https://likelet.github.io/publication/journal-article-liquid/&amp;text=Liquid%20biopsies%20to%20track%20trastuzumab%20resistance%20in%20metastatic%20HER2-positive%20gastric%20cancer" target="_blank" rel="noopener" class="share-btn-twitter">
          <i class="fab fa-twitter"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.facebook.com/sharer.php?u=https://likelet.github.io/publication/journal-article-liquid/&amp;t=Liquid%20biopsies%20to%20track%20trastuzumab%20resistance%20in%20metastatic%20HER2-positive%20gastric%20cancer" target="_blank" rel="noopener" class="share-btn-facebook">
          <i class="fab fa-facebook"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="mailto:?subject=Liquid%20biopsies%20to%20track%20trastuzumab%20resistance%20in%20metastatic%20HER2-positive%20gastric%20cancer&amp;body=https://likelet.github.io/publication/journal-article-liquid/" target="_blank" rel="noopener" class="share-btn-email">
          <i class="fas fa-envelope"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.linkedin.com/shareArticle?url=https://likelet.github.io/publication/journal-article-liquid/&amp;title=Liquid%20biopsies%20to%20track%20trastuzumab%20resistance%20in%20metastatic%20HER2-positive%20gastric%20cancer" target="_blank" rel="noopener" class="share-btn-linkedin">
          <i class="fab fa-linkedin-in"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="whatsapp://send?text=Liquid%20biopsies%20to%20track%20trastuzumab%20resistance%20in%20metastatic%20HER2-positive%20gastric%20cancer%20https://likelet.github.io/publication/journal-article-liquid/" target="_blank" rel="noopener" class="share-btn-whatsapp">
          <i class="fab fa-whatsapp"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://service.weibo.com/share/share.php?url=https://likelet.github.io/publication/journal-article-liquid/&amp;title=Liquid%20biopsies%20to%20track%20trastuzumab%20resistance%20in%20metastatic%20HER2-positive%20gastric%20cancer" target="_blank" rel="noopener" class="share-btn-weibo">
          <i class="fab fa-weibo"></i>
        </a>
      </li>
    
  </ul>
</div>











  
  
    




  
    




  
    




  
    




  
    




  
    




  
    




  
    



  
  
  
  
  
  <div class="media author-card content-widget-hr">
    
      
      <a href="/author/qi-zhao/"><img class="avatar mr-3 avatar-circle" src="/author/qi-zhao/avatar_hubfa6ca2e6c68587649f1935fb1a2bafd_156692_270x270_fill_lanczos_center_3.png" alt="Qi Zhao"></a>
    

    <div class="media-body">
      <h5 class="card-title"><a href="/author/qi-zhao/">Qi Zhao</a></h5>
      <h6 class="card-subtitle">Associate Professor of Cancer Bioinformatics</h6>
      <p class="card-text">Qi Zhao is an assistant professor of cancer bioinfomatics at the Sun Yat-sen university cancer center. His research interests include cancer genomics, biosoftware development and high performance computing.</p>
      <ul class="network-icon" aria-hidden="true">
  
    
    
    
      
    
    
    
    
    
    <li>
      <a href="mailto:zhaoqi@sysucc.org.cn" >
        <i class="fas fa-envelope"></i>
      </a>
    </li>
  
    
    
    
      
    
    
    
    
    
      
    
    <li>
      <a href="https://twitter.com/qi_likelet" target="_blank" rel="noopener">
        <i class="fab fa-twitter"></i>
      </a>
    </li>
  
    
    
    
    
    
    
    
      
    
    <li>
      <a href="https://scholar.google.co.uk/citations?user=j7LCthMAAAAJ" target="_blank" rel="noopener">
        <i class="ai ai-google-scholar"></i>
      </a>
    </li>
  
    
    
    
      
    
    
    
    
    
      
    
    <li>
      <a href="https://github.com/gcushen" target="_blank" rel="noopener">
        <i class="fab fa-github"></i>
      </a>
    </li>
  
</ul>

    </div>
  </div>


  
    




  
    




  
    




  














  
  
  <div class="article-widget content-widget-hr">
    <h3>Related</h3>
    <ul>
      
      <li><a href="/publication/journal-article-novel/">Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer</a></li>
      
      <li><a href="/publication/journal-article-rmvar/">RMVar: an updated database of functional variants involved in RNA modifications</a></li>
      
      <li><a href="/publication/journal-article-systematic-analysis/">Systematic analysis of the transcriptome in small‐cell carcinoma of the oesophagus reveals its immune microenvironment</a></li>
      
      <li><a href="/publication/journal-article-targeting/">Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells</a></li>
      
      <li><a href="/publication/journal-article-crossicc/">CrossICC: iterative consensus clustering of cross-platform gene expression data without adjusting batch effect</a></li>
      
    </ul>
  </div>
  





  </div>
</div>
  </div>

  <div class="page-footer">
    
    
    <div class="container">
      <footer class="site-footer">

  

  

  

  
  






  <p class="powered-by">
    
    
    
      
      
      
      
      
      
      Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target="_blank" rel="noopener">Wowchemy</a> — the free, <a href="https://github.com/wowchemy/wowchemy-hugo-modules" target="_blank" rel="noopener">open source</a> website builder that empowers creators.
    
  </p>
</footer>

    </div>
    
  </div>

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

      

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.5.1/jquery.min.js" integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/instant.page/5.1.0/instantpage.min.js" integrity="sha512-1+qUtKoh9XZW7j+6LhRMAyOrgSQKenQ4mluTR+cvxXjP1Z54RxZuzstR/H9kgPXQsVB8IW7DMDFUJpzLjvhGSQ==" crossorigin="anonymous"></script>

      
      
        <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
        <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      

      
      

      

      

    

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.7.1/leaflet.min.js" integrity="sha512-SeiQaaDh73yrb56sTW/RgVdi/mMqNeM2oBwubFHagc5BkixSpP1fvqF47mKzPGWYSSy4RwbBunrJBQ4Co8fRWA==" crossorigin="anonymous"></script>
    

    
    

    
    
    
      
      <script id="search-hit-fuse-template" type="text/x-template">
        <div class="search-hit" id="summary-{{key}}">
          <div class="search-hit-content">
            <div class="search-hit-name">
              <a href="{{relpermalink}}">{{title}}</a>
              <div class="article-metadata search-hit-type">{{type}}</div>
              <p class="search-hit-description">{{snippet}}</p>
            </div>
          </div>
        </div>
      </script>
      
        <script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js" integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin="anonymous"></script>
        <script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js" integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin="anonymous"></script>
      
    

    
    

    
    
    
    

    
    <script src="/js/bootstrap.bundle.min.6aed84840afc03ab4d5750157f69c120.js"></script>

    
    
      
      
      
      
      
      
      
    

    
    
    
    
    
    
    
    
      
      
    
    
    <script src="/en/js/wowchemy.min.fb8eb32a4d207f5f18023712a904b210.js"></script>

    






</body>
</html>
